Antibiotic a 42867 derivative
AssigneeMerrell Dow Pharmaceuticals Inc.
InventorsErnesto Riva, Maurizio Denaro, Pietro Ferrari, Giovanni Cassani
Life of this patent
Estimating the term…
Abstract
The present invention is directed to a new antibiotic substance denominated antibiotic A 42867 pseudoaglycon, a pharmaceutically acceptable salt thereof, a process for its preparation from antibiotic A 42867 and pharmaceutical compositions containing the new substance of the invention.
Claims11
Antibiotic A 42867 pseudoaglycon and the pharmaceutically acceptable salts thereof having the following the formula (unsalified compound):
- ##STR6## wherein B represents a beta-vancosamine unit of formula ##STR7## and the tautomers thereof.
Antibiotic A 42867 pseudoaglycon and the pharmaceutically acceptable salts thereof having the following physico-chemical parameters (unsalified form):
- (A) ultraviolet absorption which exhibits the following absorption maxima:
- ______________________________________ Lambda max (nm) ______________________________________ (a) 0.1 N HCl 279 (b) Water 279 305 (shoulder) (c) phosphate buffer pH 7.4 279 (e) 0.1 N KOH 299 265 (shoulder) ______________________________________
- (B) infrared absorption spectrum in nujol mull which exhibits the following absorption maxima (cm-.sup.-1):
- 3700-3100, 3000-2800 (nujol);
- 1650;
- 1590;
- (nujol);
- 1375 (nujol);
- 1305;
- 1240;
- 1210;
- 1160;
- 1130;
- 1060;
- 1010;
- 950;
- 870;
- 835;
- 720 (nujol)
- (C) .sup.l H-NMR spectrum which exhibits the following groups of signals (in ppm) at 250 MHz (Bruker Instruments) recorded in DMSO d.sub.6 (hexadeuterodimethylsulfoxide) using TMS as the internal standard (0.00 ppm), (delta=ppm):
- Sugar moiety:
- 1. 22,d [CH.sub.3 --(CH)];
- 1.50,s [CH.sub.3 --C(NH.sub.2)];
- 2.25, m [CH.sub.2 --(CH)];
- 3.60, m [CH--(CH.sub.3)];
- 4.90, d (anomeric proton)
- Core moiety:
- ##STR8##
- 2. 32, s [CH.sub.3 --(NH];
- 2.49, s (solvent DMSOd.sub.5);
- 3.35, br [H.sub.2 O];
- 4.23-6.35 [aromatic and peptidic CH's];
- 6.35-9.50 [aromatic CH's, peptidic NH's and phenolic OH's]
- s=singlet;
- d=doublet;
- m=multiplet;
- br=broad
- (D) retention time (R.sub.t) of 2.88 relative to antibiotic A 42867 (R.sub.t =8.45 min) when analyzed by reverse phase HPLC under the following conditions:
- column:
- Ultrasphere ODS (5 micrometer) Altex (Beckman) 4.6 mm (i.d.).times.250 mm
- pre-column:
- 3 cm Brownlee Labs RP 18 (5 micrometer)
- eluents:
- (A) (2.5 gr/l) NaH.sub.2 PO.sub.4 /CH.sub.3 CN, 98:2 (v/v) adjusted to pH 6.0
- (B) (2.5 gr/l) NaH.sub.2 PO.sub.4 /CH.sub.3 CN, 30:70 (v/v) adjusted to pH 6.0
- Elution mode:
- linear gradient from 5% to 60% of B in A in 40 min
- flow rate:
- 1.8 ml/min
- U.V. detector:
- 254 nm
- internal standard:
- antibiotic A 42867 (R.sub.t =8.45 min)
- (E) elemental analysis showing the presence of one chlorine atom per molecule
- (F) 2D .sup.1 H-NMR NOESYPH analysis showing that the molecular chlorine atom is on ring 2 and not on ring 6, on the basis of Nuclear Overhauser effect (dipolar coupling through space) and scalar coupling through chemical bond, in fact:
- (a) on the basis of scalar coupling, proton 2b (see formula I) shows only a meta coupling with 2f but no ortho coupling;
- (proton 2b is on ring 2 and not on ring 6 on the basis of the following dipolar coupling:
- 2b .fwdarw.Z'2;
- 2b .fwdarw.(Z2)OH;
- (Z2)OH .fwdarw.Z'2;
- Z'2.fwdarw.X2)
- (b) on the basis of scalar coupling, proton 6b (see formula I) shows an ortho coupling with proton 6c (dipolar coupling 6b.fwdarw.6c;
- Z6-6b;
- Z6.fwdarw.X6)
- (G) a fast atom bombardament (FAB) mass spectrum with M+H.sup.+ at about 1251 (the theoretical cluster ion peaks for the formula C.sub.60 H.sub.64 N.sub.9 O.sub.19 Cl+H range from 1250 to 1255, average value 1251.68). The FAB spectrum was obtained with a VG 70-250 instrument, bombarding gas Xenon;
- beam energy 8 KV;
- accelerating voltage 6kV;
- matrix thioglycerol-glycerol, 2:.
- (H) acid and basic functions capable of forming salts.
Dependencies are inferred from the claim text.